Literature DB >> 7250530

Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats.

T Ishibashi, K Tanaka, Y Taniguchi.   

Abstract

Fifty male rats were made diabetic by a single injection of streptozotocin and were killed at periods varying from 1 to 12 mo. Ten saline-injected rats and three rats treated with 3-O-methylglucose and streptozotocin served as controls. Intraluminal changes in retinal vessels were studied by electron microscopy. In diabetic rats maintained for 9-12 mo, microthrombus formation was observed in the various sized retinal vessels at the histologic and ultrastructural level. The microthrombi were mainly composed of aggregated platelets and fibrin strands. However, there was no definite evidence of detachment or loss of the endothelial cells. This microthrombus formation may play an important role in the development of diabetic retinopathy.

Entities:  

Mesh:

Year:  1981        PMID: 7250530     DOI: 10.2337/diab.30.7.601

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Authors:  R Donnelly; I Idris; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

Review 2.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

3.  The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.

Authors:  Eric Davidson; Lawrence Coppey; Bao Lu; Victor Arballo; Nigel A Calcutt; Craig Gerard; Mark Yorek
Journal:  Exp Diabetes Res       Date:  2010-02-03

4.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H Takeda; H Kishikawa; M Shinohara; T Miyata; K Suzaki; H Fukushima; K Ichinose; M Shichiri
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

6.  MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy.

Authors:  M Citirik; E Beyazyildiz; M Simsek; O Beyazyildiz; I C Haznedaroglu
Journal:  Eye (Lond)       Date:  2014-12-19       Impact factor: 3.775

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

Review 8.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

9.  Reflow of obstructed capillaries in the maculae of humans with diabetic retinopathy, observed by fluorescein angiography.

Authors:  Y Yamana; Y Oka; Y Ohnishi; T Ishibashi; T Inoguchi
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

10.  Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown.

Authors:  Kenji Yamashiro; Akitaka Tsujikawa; Susumu Ishida; Tomohiko Usui; Yuichi Kaji; Yoshihito Honda; Yuichiro Ogura; Anthony P Adamis
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.